|  Download for Citation Managers
SHORT COMMUNICATION
Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors
Cure Erkan, Kucuk Adem, Cure Medine Cumhur
Year : 2021 | Volume: 53 | Issue Number: 3 | Page: 226-228
Click here to read this article
|
| |
|
